building a homegrown data management system: perspectives ... cps 2 - abebe.pdf · building a...
TRANSCRIPT
Overview of HALT-PKD “On the fly fixes” Conclusions
Building a Homegrown Data Management System:Perspectives from the HALT-PKD Trials
Kaleab Z. Abebe
Assistant Professor of Medicine, Biostatistics, and Clinical & Translational SciencesCenter for Research on Health Care Data Center
University of Pittsburgh School of Medicine
May 18, 2015
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
1 Overview of HALT-PKD
2 “On the fly fixes”Outcome AdjudicationMaster Regulatory File
3 Conclusions
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
1 Overview of HALT-PKD
2 “On the fly fixes”Outcome AdjudicationMaster Regulatory File
3 ConclusionsKaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Overview
Autosomal Dominant PolycysticKidney Disease (ADPKD)
4th leading cause of end-stagerenal disease (ESRD).
Kidney cyst growth =⇒increased kidney volume,activation of the RAAS,hypertension, and renal failure.
No evidence BP control or RAASblockade slows the progression ofrenal disease.
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
HALT-PKD Trials
Study A: Participants & Trial Design
558 young (15-49 yrs) and healthy (eGFR > 60) participants
Randomized in 2x2 design to:
ACE-I + ARB or ACE-I alone
standard (120-130/70-80 mmHg) or low (95-110/60-75 mmHg) BP
Study B: Participants & Trial Design
486 slightly older (18-64 yrs) participants with moderately advanceddisease (eGFR 20-60).
Randomized to:
ACE-I + ARB or ACE-I alone
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
HALT-PKD Consortium Map
HALT%PKD%Clinical%Catchment%Zones%
U. Colorado
Mayo
CCF
Pitt (DCC)
Tufts
BIDMC
U. Kansas
Emory
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Data Coordinating Center
Transition of DCC
DCC originally housed at another institution
In 2009, transfered to CRHC-DC
Personnel
PI: Charity Moore, PhD
Co-I & Lead Statistician: Kaleab Abebe, PhD
Lead Research Coordinator: Susan Spillane, RN, CCRP
Statisticians: Diane Comer, Jie Li, Elan Cohen
Systems Analysts: Joe Weiss, Terry Sefcik, Linda Quinn, Shelly Rowe
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Data Coordinating Center Responsibilities
Aim 1
“To serve as the HALT-PKD DCC by collaborating with studyinvestigators, managing protocol and regulatory compliance, facilitatingthe transfer of data, and supporting HALT-PKD activities for qualitycontrol, endpoint adjudication, and blood pressure management.”
Aim 2
“Maintain the Web-based data management system that incorporatesdata tracking, entry, quality control, and report generation.”
Aim 3
“Conduct interim and final statistical analyses to support the aims ofthe study including the primary analyses for Study A and Study B.”
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
electronic System for Data Management (eSYSDM)
Web-based data entry and tracking system; data stored on SQL server
Facilitates automatic import of centralized laboratory results
Allows real-time reporting of visit completeness, follow-up tracking,drug dosage, specimen inventory, and blood pressure reports.
“On the fly fixes”
During the course of the study, there were 2 major changes the DCChad to make:
Integration of outcome adjudication process into web-based system
Creation of an electronic regulatory management system
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Outcome Adjudication
1 Overview of HALT-PKD
2 “On the fly fixes”Outcome AdjudicationMaster Regulatory File
3 ConclusionsKaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Outcome Adjudication
Overview
All-cause and CV-related hospitalizations are secondary outcomes forboth Study A & B.
All AEs reviewed during monthly QC call
Need to adjudicate hospitalization based on discharge summaryinformation
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Outcome Adjudication
Hospitalization adjudication portal 1.0
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Outcome Adjudication
Hospitalization adjudication portal 2.0
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Outcome Adjudication
Hospitalization adjudication portal 2.0
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Outcome Adjudication
Hospitalization adjudication portal 2.0
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Outcome Adjudication
Hospitalization adjudication portal 2.0
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Outcome Adjudication
Hospitalization adjudication portal 2.0
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Outcome Adjudication
Hospitalization adjudication portal 2.0
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Outcome Adjudication
Hospitalization adjudication portal 2.0
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Outcome Adjudication
Hospitalization adjudication portal 2.0
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Master Regulatory File
Overview
In 2012, the need for a centralized Regulatory system was identified.
Design and implementation of Sharepoint MRF system was completedwhile writing the closeout protocol.
ICH E6 Good Clinical Practice as a guidance for what to include.
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Master Regulatory File
Master Regulatory File
SHARED FILES SITE SPECIFIC FILES
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Master Regulatory File
Master Regulatory File
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Master Regulatory File
Master Regulatory File
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Master Regulatory File
Master Regulatory File
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Master Regulatory File
Master Regulatory File
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Master Regulatory File
Master Regulatory File
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Master Regulatory File
Master Regulatory File
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Master Regulatory File
Master Regulatory File
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
1 Overview of HALT-PKD
2 “On the fly fixes”Outcome AdjudicationMaster Regulatory File
3 ConclusionsKaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Take Home Messages
Hospital Adjudication
Outcomes that require adjudication must have secure, systematic, andreproducible review to ensure the integrity of their results.
Master Regulatory File
Develop a standardized regulatory file system withguidance/justification for required documentation at the initiation ofclinical trial activities
promotes regulatory compliance
educational tool for regulatory-naive coordinators
aids in remote monitoring of multi-centered trials
Kaleab Z. Abebe HALT-PKD Clinical Trials
Overview of HALT-PKD “On the fly fixes” Conclusions
Acknowledgements
Kaleab Z. Abebe HALT-PKD Clinical Trials